Pontificia Universidad Catolica de Chile: COVID-19 trials

The registry lists 13 COVID-19 studies with Pontificia Universidad Catolica de Chile as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 3Phase 3 2No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in ChileCompletedNCT05593042Phase 2
• Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ TransplantCompletedNCT05124509
• Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active TreatmentStatus unknownNCT05119738
• Impact of a Communication Strategy in the Prevention of Depressive Symptoms in Patients with Covid-19CompletedNCT05035563Not applicable
• Long-term Neurocognitive and Psychiatric Consequences in Severe COVID-19 Survivors.Status unknownNCT05019300
• Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19)CompletedNCT04988217Phase 1/2
• Immune Response to Anti COVID-19 Vaccine in Immunocompromised Patients: a Cohort StudyCompletedNCT04888793
• Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in AdultsCompletedNCT04651790Phase 3
• Prone Position for Nonintubated Patients With COVID-19 and Hypoxemic Respiratory FailureCompletedNCT04641182
• Cardiac Performance in Mechanically Ventilated COVID-19 PatientsCompletedNCT04628195
• The Containing Coronavirus Disease 19 (COVID-19) TrialCompletedNCT04552379Phase 3
• Mental Health Impact of the COVID-19 Pandemic Among Migrants in ChileCompletedNCT04497636
• Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 InfectionCompletedNCT04375098Phase 2